Skip to main content

Table 1 Patient characteristics (n = 50)

From: Expression of Par3 polarity protein correlates with poor prognosis in ovarian cancer

  No. Patients (n = 50)
Age, median (range), yr 57 (32–80)
Follow-up period (m) 59.1 (2–120)
FIGO
 Stage I 25 (50%)
 Stage II 4 (8%)
 Stage III 12 (24%)
 Stage IV 9 (18%)
Histology
 High-grade serous 16 (30%)
 Endometrioid 12 (8%)
 Clear cell 22 (44%)
Dissemination and metastasis at diagnosis (overlapped, depending on the cases)
 Dissemination 18 (36%)
 Lymph node metastasis 12 (24%)
 Distant metastasis 3 (0.6%)
Recurrent site (overlapped, depending on the cases)
 Dissemination 17 (34%)
 Lymph node metastasis 10 (20%)
 Distant metastasis 6 (12%)
Par3 expression
 High 10 (20%)
 Intermediate 10 (20%)
 Low 30 (60%)